Novartis Pharma AG: Novartis appoints Rob Kowalski as Chief People & Organization Officer
Basel, June 28, 2021 - Novartis announced today the appointment of Rob Kowalski, Pharm.D., Global Head Regulatory Affairs and US Head of Drug Development as Chief People & Organization Officer. He will report to Vas Narasimhan, M.D., CEO of Novartis and become a member of the Executive Committee of Novartis (ECN), effective September 1, 2021.
Steven Baert, currently Chief People & Organization Officer, will step down from the Executive Committee of Novartis, effective June 30, 2021 after 15 years with the company and almost 8 years in position. Vicki Rawlinson, US Head People & Organization will lead the function ad-interim until Dr. Kowalski takes over.
Novartis AG (via Public) / Novartis International AG Novartis Global Communications CH-4002 Basel Switzerland (Form 6-K) publicnow.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from publicnow.com Daily Mail and Mail on Sunday newspapers.
Home / Top News / InvestorBrandNetwork (IBN) and BioMedWire (BMW) Announce Collaboration with Q1 Productions to Serve as Official Media Sponsors for Upcoming Event Schedule
InvestorBrandNetwork (IBN) and BioMedWire (BMW) Announce Collaboration with Q1 Productions to Serve as Official Media Sponsors for Upcoming Event Schedule
LOS ANGELES, May 31, 2021 (GLOBE NEWSWIRE) via InvestorWire
InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company, today announces that it will collaborate with Q1 Productions as an official media sponsor for its full event lineup in 2021. IBN also simultaneously announces that
BioMedWire (“BMW”), a specialized communications platform for the life sciences sector and
one of the 50+ brands part of the InvestorBrandNetwork, will also be joining as an official media sponsor for Q1 Productions’ upcoming events.
Viasat continues its opposition against
SpaceX’s Starlink constellation on environmental grounds, and said in its latest filing to the
FCC that if the commission does not stay its approval of SpaceX’s Starlink altitude change, Viasat intends to seek a stay from the U.S. Court of Appeals for the District of Columbia Circuit.
The issue in question is that the FCC granted SpaceX’s request to lower the altitude of future satellites in the Starlink Low-Earth Orbit (LEO) constellation. The FCC’s decision in April came despite protests from Viasat,
Amazon,
SES, and other satellite competitors.
“We believe the FCC failed to conduct a legally required environmental review under NEPA [National Environmental Policy Act] and did not honor the Biden-Harris administration’s commitment to a science-based approach to protecting the atmosphere, the Earth’s climate, space and the well-being of U.S. citizens before authorizing the launch of thousands of new Starlink satellit
Biocon brings first-of-its-kind programme in Global Regulatory Affairs
Biocon brings first-of-its-kind programme in Global Regulatory Affairs
11 May 2021 | News
Image credit- shutterstock.com
Biocon Academy, a CSR initiative of global biopharmaceutical company, Biocon, and a Center of Excellence for Advanced Learning in Biosciences, has introduced a new and unique programme in Global Regulatory Affairs (GRA) in collaboration with JSS Academy of Higher Education and Research (JSS AHER), Mysuru.
The exclusive programme is designed to impart applied knowledge on various good regulatory practices, clinical development processes, documentation and submission of filings, regulations for drugs, biologics and medical devices and legislation in regulated and emerging markets through an intensive curriculum.